Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?

While Pfizer's dividend looks like a trap, its strong balance sheet and low valuation make it safer.

With the Market Flashing Warning Signs Not Seen Since the Dot-Com Bust, Is Pfizer's 6% Yield a Safe Haven or a Trap?

Published September 29, 2026 · Category: Finance

Overview

The Shiller CAPE Ratio is at its second-highest reading in 150 years. The last time it was this high was right before the dot-com bubble burst, with the S&P 500 Index (SNPINDEX:^GSPC) crashing nearly 50% over the next two and a half years. That elevated market valuation indicator has me looking for more safe investments.

I came across Pfizer (NYSE:PFE) while screening for quality dividend stocks to buy amid the current market environment. While its high 6% yield initially looked like a trap, the more I dig into Pfizer, the more I see a potential safety net for a looming market storm.

Image source: The Motley Fool.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.